ClinicalTrials.gov
public full text
Public Domain
VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease
To assess blood levels of vasoactive mediators that may regulate pulmonary endothelial permeability and contribute to multi-organ injury in patients with COVID-19 disease and to correlate the levels of these mediators with disease outcomes such as ICU admission, length of ventilatory support, respiratory failure, kidney failure, heart failure, and death.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Polygenic risk scores enhance the identification of carriers of monogenic forms of idiopathic pulmonary fibrosis#192358
- Home Monitoring and Molecular Phenotyping of Patients With Post-COVID With Focus on Lung Involvement#811017
- Therapeutic potential of young plasma in reversing age-related liver inflammation via modulation of NLRP3 inflammasome and necroptosis#397885
- Respiratory Virus Metagenomics After COVID-19#1029836
- Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients#884128
Record · ID 1072169
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive